Market Leaders - Flumazenil Industry

Mar, 2023 - by CMI

Market Leaders - Flumazenil Industry

Industry participants are focusing on the introduction of new items. Also an increasing proportion of people suffer from anxiety problems. Throughout the projected period, this is likely to fuel expansion in the worldwide flumazenil market. Regulatory authorities are revising flumazenil dosage guidelines for the treatment of benzodiazepine overdose, which is projected to boost growth in the worldwide flumazenil market. Throughout the projected period, the increasing adverse effects of the Flumazenil medicine are likely to impede growth in the global flumazenil market. Throughout the projected period, regulatory clearance for the use of flumazenil is likely to boost growth in the worldwide flumazenil market.

According to Coherent Market Insights, Global Flumazenil Market is estimated to be valued at US$ 20.528 Mn in 2022 and is expected to exhibit a CAGR of 2.8% over the forecast period (2022-2030)

Prominent Players in the Flumazenil Industry:

1.  Hoffmann La Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics. The company was founded in 1896 and is headquartered in Basel, Switzerland.

2. Akorn-Strides, LLC

Akorn is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded. The company is headquartered in Illinois, U.S. founded in 1948.

3. Sandoz Canada Incorporated

Sandoz Canada is manufacturing healthcare product and medicine. The company was founded in 1980, headquartered in Canada.

4. Fresenius Kabi USA, LLC

Fresenius Kabi is health care company specializing in medical and medical technologies. The company was founded in 1996, headquartered in Illinois, U.S.

5. Mylan Pharmaceuticals

From 1961 to 2020, Mylan was one of the world’s leading generics and specialty pharmaceutical companies, providing products to customers in approximately 140 countries and territories.
On Jul 29, 2019
Mylan acquired The Upjohn Company 

6. Sina Health Inc

The company is known working to remove inequalities in musculoskeletal healthcare through the development and integration of digital services. Headquartered in U.K, company was founded in April, 2020.

7.  West Ward Pharmaceutical

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

8. Hikma Farmaceutica

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.  It operates through three segments: Injectables, Generics, and Branded. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.

9. Pfizer Laboratories Div Pfizer Inc.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc.

*Definition- Flumazenil is an antagonist used orally or intravenously. In medicine, it acts as an antagonist and antidote to benzodiazepines. Flumazenil is also used in anaesthesia to awaken patients following diagnostic examinations. Flumazenil is injected into the vein, either diluted or undiluted.

LogoCredibility and Certifications

Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.